LPL Financial’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-3,283
| Closed | -$32K | – | 2968 |
|
|
2017
Q2 | $32K | Sell |
3,283
-133
| -4% | -$1.3K | ﹤0.01% | 2756 |
|
|
2017
Q1 | $86K | Buy |
3,416
+98
| +3% | +$2.47K | ﹤0.01% | 2629 |
|
|
2016
Q4 | $104K | Sell |
3,318
-203
| -6% | -$6.36K | ﹤0.01% | 2591 |
|
|
2016
Q3 | $165K | Buy |
3,521
+203
| +6% | +$9.51K | ﹤0.01% | 2446 |
|
|
2016
Q2 | $149K | Sell |
3,318
-2,682
| -45% | -$120K | ﹤0.01% | 2444 |
|
|
2016
Q1 | $391K | Buy |
6,000
+509
| +9% | +$33.2K | ﹤0.01% | 2330 |
|
|
2015
Q4 | $338K | Buy |
5,491
+2,415
| +79% | +$149K | ﹤0.01% | 2458 |
|
|
2015
Q3 | $231K | Buy |
3,076
+295
| +11% | +$22.2K | ﹤0.01% | 2412 |
|
|
2015
Q2 | $268K | Buy |
2,781
+515
| +23% | +$49.6K | ﹤0.01% | 2403 |
|
|
2015
Q1 | $215K | Buy |
2,266
+240
| +12% | +$22.8K | ﹤0.01% | 2503 |
|
|
2014
Q4 | $180K | Sell |
2,026
-395
| -16% | -$35.1K | ﹤0.01% | 2531 |
|
|
2014
Q3 | $161K | Sell |
2,421
-29
| -1% | -$1.93K | ﹤0.01% | 2526 |
|
|
2014
Q2 | $141K | Sell |
2,450
-938
| -28% | -$54K | ﹤0.01% | 2564 |
|
|
2014
Q1 | $134K | Buy |
3,388
+413
| +14% | +$16.3K | ﹤0.01% | 2529 |
|
|
2013
Q4 | $125K | Buy |
2,975
+222
| +8% | +$9.33K | ﹤0.01% | 2537 |
|
|
2013
Q3 | $75K | Sell |
2,753
-131
| -5% | -$3.57K | ﹤0.01% | 2472 |
|
|
2013
Q2 | $153K | Buy |
+2,884
| New | +$153K | ﹤0.01% | 2274 |
|